Molecular Mechanisms of Emerging Antidepressant Strategies: From Ketamine to Neuromodulation
Mateusz Kowalczyk, David Aebisher, Jakub Szpara, Sara Czech, Dorota Bartusik-Aebisher, Gabriela Henrykowska · 2025
Read Molecular Mechanisms of Emerging Antidepressant Strategies: From Ketamine to Neuromodulation by Mateusz Kowalczyk, David Aebisher, Jakub Szpara, Sara Czech, Dorota Bartusik-Aebisher, Gabriela Henrykowska (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785913.txt.
Description
Mateusz Kowalczyk and five co-authors reviewed the cellular basis of new depression treatments, from ketamine to brain stimulation, in a paper published in 2025. Depression touches more than 300 million people and raises the risk of self-harm. Its roots braid genes, stress, inflammation in the brain, and worn cell links. Standard mood drugs work on one set of signaling systems and often fall short.
New treatments hit other systems: the fast signal network, the calming network, and the drive network. Named forms span ketamine relatives, a cough drug pair, and hormone-based pills. Non-drug methods add magnetic pulses, mild current, and light applied to the skull. The team ties each treatment's cell actions to the roots of the disease. They aim at precise, matched, multi-way care.
Catalog record
| CREATOR | Mateusz Kowalczyk, David Aebisher, Jakub Szpara, Sara Czech, Dorota Bartusik-Aebisher, Gabriela Henrykowska |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 95 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |